PuroA

General Information


DRACP ID  DRACP02829

Peptide Name   PuroA

Sequence  FPVTWRWWKWWKG

Sequence Length  13

UniProt ID  P33432 

PubChem CID  Not available

Origin  Synthetic (Based Puroindoline-A)

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis Binding intracellular targets



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>250 μg/mL MTT assay 24 h 1

Hemolytic Activity  Sheep erythrocytes: No hemolysis up tp 500 µg/ml

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50=250 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02829

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C98H123N23O15

Absent amino acids  ACDEHILMNQSY

Common amino acids  W

Mass  207741

Pl  11.82

Basic residues  3

Acidic residues  0

Hydrophobic residues  7

Net charge  3

Boman Index  -898

Hydrophobicity  -96.15

Aliphatic Index  22.31

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  27500

Absorbance 280nm  2291.67

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33207639

Title  Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells

Doi 10.3390/ijms21228624

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.